Skip to main content

Table 2 SUV metrics: means ± standard deviation

From: What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours

 

NHL

HL

Sarcoma

SUVmax

14.15 ± 6.85 [11.32–16.98]

11.82 ± 4.30 [9.33–14.30]

8.36 ± 4.45 [6.27–10.44]

SUVpeak

11.86 ± 6.42 [9.22–14.51]

9.72 ± 3.84 [7.51–11.94]

6.72 ± 3.27 [5.19–8.25]

SUVmax/liver

9.61 ± 4.29 [7.84–11.38]

6.78 ± 2.40 [5.39–8.17]

6.06 ± 2.53 [4.88–7.24]

SUVmax/mediastinum

13.52 ± 6.86 [10.69–16.36]

9.76 ± 3.70 [7.62–11.90]

9.78 ± 4.98 [7.45–12.11]

SUVpeak/liver

8.09 ± 4.11 [6.40–9.79]

5.54 ± 2.13 [4.32–6.77]

4.87 ± 1.94 [3.96–5.78]

SUVpeak/mediastinum

11.39 ± 6.31 [8.78–13.99]

7.93 ± 3.06 [6.17–9.70]

7.81 ± 3.69 [6.09–9.54]

  1. NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma. In brackets: 95% confidence interval